Amersham Biosciences

Amersham comes in on track in 3Q

30-Oct-2003

Amersham yesterday gave a third quarter trading update in the
build-up to its proposed $9.5 billion (€8.1bn) acquisition by
General Electric.

Amersham sues PE for patent infringement

24-Oct-2003

Amersham Biosciences has filed a lawsuit against PerkinElmer
alleging that the latter has infringed on two of Amersham's patents
for a reagent technology used in the development of new drugs.

Amersham soars on takeover bid

09-Oct-2003

After Amersham confirmed yesterday that it had received a bid from
an unnamed suitor wishing to buy the entire company, its shares
rose more than 16 per cent; both J&J and Roche are in the
rumour mill.

Cytochrome P450 bioarray

11-Sep-2003

Amersham Biosciences has extended its CodeLink microarray range
with the launch of its Human P450 SNP Bioarray for genotyping and
pharmacogenomics.

Mouse genome array from Amersham

04-Sep-2003

Amersham Biosciences has added a mouse genome product in its
CodeLink range, used for drug target identification, pathway
characterisation and drug effect predictions.

Amersham alliance on image analysis

22-Jul-2003

Amersham Biosciences and Geneva Bioinformatics have hooked up to
provide a new version of the ImageMaster package used in 2-D gel
image analysis.

Amersham extends CyDye fluor range

15-Jul-2003

Amersham Biosciences has added to its range of CyDye mono-reactive
fluor dyes with two products used for labelling proteins or
antibodies in protein array experiments.